Supernus Pharmaceuticals (SUPN) EV to EBITDA (2015 - 2025)
Supernus Pharmaceuticals' EV to EBITDA came in at 86.99 for Q4 2025, up 802.6% from 9.64 a year earlier and up 72.1% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) EV to EBITDA (2015 - 2025) Analysis & Trends
Going back to Q1 2015, Supernus Pharmaceuticals' EV to EBITDA data covers 44 quarters.
- Going back by year, EV to EBITDA was 9.64 in FY2024 (-42.3%), 16.70 in FY2023 (+49.1%), 11.19 in FY2022 (+9.4%) and 10.23 in FY2021 (+116.2%).
- The Q4 2025 figure represents the highest quarterly EV to EBITDA in data going back to Q1 2015.
- Year-over-year, EV to EBITDA increased in three of the last eight quarters, with growth averaging 144.3%.
- The fastest year-over-year change in EV to EBITDA over five years came in Q4 2025 (growth of 802.6%), and the weakest in Q1 2025 (a decline of 59.7%).
- Business Quant data shows SUPN's EV to EBITDA at 50.54 (Q3 2025), 8.61 (Q2 2025) and 8.86 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 86.99 |
| Sep 30, 2025 | 50.54 |
| Jun 30, 2025 | 8.61 |
| Mar 31, 2025 | 8.86 |
| Dec 31, 2024 | 9.64 |
| Sep 30, 2024 | 9.25 |
| Jun 30, 2024 | 10.09 |
| Mar 31, 2024 | 21.97 |
| Dec 31, 2023 | 16.70 |
| Sep 30, 2023 | 11.36 |
| Jun 30, 2023 | 14.18 |
| Mar 31, 2023 | 12.95 |
| Dec 31, 2022 | 11.19 |
| Sep 30, 2022 | 14.81 |
| Jun 30, 2022 | 10.32 |
| Mar 31, 2022 | 11.54 |
| Dec 31, 2021 | 10.23 |
| Sep 30, 2021 | 6.51 |
| Jun 30, 2021 | 7.04 |
| Mar 31, 2021 | 5.49 |
API Access
Supernus Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();